Lufuradom
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C22H20FN3O2 |
Molar mass | 377.419 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
Lufuradom (INN) is a drug and benzodiazepine derivative which, unlike other benzodiazepines, is described as an analgesic.[1] Similarly to its analogue tifluadom, it was never marketed.
See also
- Tifluadom
- GYKI-52895, structural benzodiazepine which is a dopamine reuptake inhibitor without GABAergic function
- GYKI-52,466, structural benzodiazepine which is an AMPAkine and glutamate antagonist without GABAergic function
References
- ↑ World Health Organization (31 December 1988). International nonproprietary names (INN) for pharmaceutical substances, 1988: lists 1-58 of proposed INN and lists 1-27 of recommended INN : cumulative list. World Health Organization. p. 252. ISBN 978-92-4-056014-7. Retrieved 26 April 2012.
Opioid receptor modulators | |
---|---|
MOR |
|
DOR |
|
KOR |
|
NOP |
|
Unsorted |
|
Others |
|
1,4-Benzodiazepines |
|
---|---|
1,5-Benzodiazepines | |
2,3-Benzodiazepines* |
|
Triazolobenzodiazepines | |
Imidazobenzodiazepines | |
Oxazolobenzodiazepines | |
Thienodiazepines | |
Thienotriazolodiazepines | |
Thienobenzodiazepines* | |
Pyridodiazepines | |
Pyridotriazolodiazepines | |
Pyrazolodiazepines | |
Pyrrolodiazepines | |
Tetrahydroisoquinobenzodiazepines | |
Pyrrolobenzodiazepines* | |
Benzodiazepine prodrugs | |
* atypical activity profile (not GABAA receptor ligands) |
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.